TNNI3 and COVID-19: Progressive increased levels of C-reactive protein and N-terminal pro-B-type natriuretic peptide (NT-proBNP) coexisted with elevated cTnI levels in these COVID-19 patients, which enhance the severity of inflammation and ventricular dysfunction.